Uses
Pentetate Indium Disodium In 111 is recommended for use in radionuclide cisternography.
Source: US FDA prescribing information
Molecule
Indium in-111 pentetate is a radioactive diagnostic agent. It is available as injection for intrathecal use. MedsAcross supplies Indium in-111 pentetate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
From the regulator-approved product information. Each section names its source.
Pentetate Indium Disodium In 111 is recommended for use in radionuclide cisternography.
Source: US FDA prescribing information
Extreme care must be exercised to assure aseptic conditions in intrathecal injections. The maximum recommended intrathecal dose in the average patient (70 kg) is
Source: US FDA prescribing information
None known.
Source: US FDA prescribing information
The contents of the vial are radioactive. Adequate shielding of the preparation must be maintained at all times. Since the drug is excreted by the kidneys, caution should be exercised in patients with severely impaired renal function.
Source: US FDA prescribing information
Aseptic meningitis and pyrogenic reactions have been rarely (less than 0.4%) observed following cisternography with Pentetate lndium Disodium In 111. One death has been reported to have occurred within 20 minutes following the administration of Pentetate Indium Disodium In 111 and appears to be drug related. In addition, two cases of septic meningitis have also been reported. There have also been reports of skin reactions and vomiting following administration of Pentetate lndium Disodium In 111. Relationship of the drug to these latter occurrences has not been established.
Source: US FDA prescribing information
Store vial in its lead shield at a temperature of 5°-30°C (41°-86°F). Do not freeze.
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
1 presentations of Indium in-111 pentetate, sorted by availability.
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Indium DTPA In 111 1 mCi/mL injectionIntrathecal | GE Healthcare | US FDA | Available on request |
1 brand names across 1 markets.
United States
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | First approved 18 February 1982 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Yes, on request. MedsAcross lists 1 presentations of Indium in-111 pentetate and sources them for licensed hospitals, importers and physicians against valid import documents.
The catalogue lists 1 brand names for Indium in-111 pentetate, including Indium DTPA In 111.
Yes. The US FDA first approved Indium in-111 pentetate on 18 February 1982, according to Drugs@FDA.
No listed presentation of Indium in-111 pentetate is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.